nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Methotrexate—ankylosing spondylitis	0.256	0.331	CbGbCtD
Ceftriaxone—ALB—Prednisone—ankylosing spondylitis	0.176	0.228	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—ankylosing spondylitis	0.149	0.193	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—ankylosing spondylitis	0.104	0.134	CbGbCtD
Ceftriaxone—ALB—Methotrexate—ankylosing spondylitis	0.0882	0.114	CbGbCtD
Ceftriaxone—Alveolitis allergic—Methotrexate—ankylosing spondylitis	0.00489	0.0214	CcSEcCtD
Ceftriaxone—Haematocrit decreased—Methotrexate—ankylosing spondylitis	0.00342	0.015	CcSEcCtD
Ceftriaxone—Lymphopenia—Prednisone—ankylosing spondylitis	0.00298	0.0131	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Prednisolone—ankylosing spondylitis	0.00284	0.0124	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Triamcinolone—ankylosing spondylitis	0.00261	0.0114	CcSEcCtD
Ceftriaxone—Fungal infection—Methylprednisolone—ankylosing spondylitis	0.0025	0.0109	CcSEcCtD
Ceftriaxone—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00238	0.0105	CcSEcCtD
Ceftriaxone—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.00238	0.0104	CcSEcCtD
Ceftriaxone—Fungal infection—Betamethasone—ankylosing spondylitis	0.00227	0.00995	CcSEcCtD
Ceftriaxone—Fungal infection—Dexamethasone—ankylosing spondylitis	0.00227	0.00995	CcSEcCtD
Ceftriaxone—Glycosuria—Dexamethasone—ankylosing spondylitis	0.00216	0.00948	CcSEcCtD
Ceftriaxone—Glycosuria—Betamethasone—ankylosing spondylitis	0.00216	0.00948	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Prednisone—ankylosing spondylitis	0.00206	0.00904	CcSEcCtD
Ceftriaxone—Leukocytosis—Methylprednisolone—ankylosing spondylitis	0.00205	0.00899	CcSEcCtD
Ceftriaxone—Fungal infection—Prednisone—ankylosing spondylitis	0.00198	0.00867	CcSEcCtD
Ceftriaxone—Glycosuria—Prednisone—ankylosing spondylitis	0.00188	0.00826	CcSEcCtD
Ceftriaxone—Leukocytosis—Dexamethasone—ankylosing spondylitis	0.00186	0.00818	CcSEcCtD
Ceftriaxone—Leukocytosis—Betamethasone—ankylosing spondylitis	0.00186	0.00818	CcSEcCtD
Ceftriaxone—Candida infection—Triamcinolone—ankylosing spondylitis	0.00184	0.00808	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.00176	0.00772	CcSEcCtD
Ceftriaxone—Fungal infection—Methotrexate—ankylosing spondylitis	0.00165	0.00724	CcSEcCtD
Ceftriaxone—Leukocytosis—Prednisone—ankylosing spondylitis	0.00162	0.00712	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.00162	0.0071	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.00162	0.00708	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00158	0.00691	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00147	0.00644	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00147	0.00644	CcSEcCtD
Ceftriaxone—Proteinuria—Methotrexate—ankylosing spondylitis	0.00145	0.00636	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00145	0.00635	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00145	0.00634	CcSEcCtD
Ceftriaxone—Protein urine present—Methotrexate—ankylosing spondylitis	0.00143	0.00628	CcSEcCtD
Ceftriaxone—Oliguria—Methotrexate—ankylosing spondylitis	0.00138	0.00607	CcSEcCtD
Ceftriaxone—Glossitis—Methotrexate—ankylosing spondylitis	0.00138	0.00607	CcSEcCtD
Ceftriaxone—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00133	0.00584	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00131	0.00576	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00131	0.00576	CcSEcCtD
Ceftriaxone—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00129	0.00566	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisolone—ankylosing spondylitis	0.00128	0.00563	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00128	0.00561	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00128	0.00559	CcSEcCtD
Ceftriaxone—Vaginal infection—Methotrexate—ankylosing spondylitis	0.0012	0.00528	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.0012	0.00525	CcSEcCtD
Ceftriaxone—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00119	0.00521	CcSEcCtD
Ceftriaxone—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00119	0.00521	CcSEcCtD
Ceftriaxone—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00119	0.0052	CcSEcCtD
Ceftriaxone—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00118	0.00517	CcSEcCtD
Ceftriaxone—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00118	0.00516	CcSEcCtD
Ceftriaxone—Sweating increased—Betamethasone—ankylosing spondylitis	0.00107	0.0047	CcSEcCtD
Ceftriaxone—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00107	0.0047	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00107	0.00469	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00106	0.00465	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00105	0.00462	CcSEcCtD
Ceftriaxone—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00102	0.00447	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000981	0.0043	CcSEcCtD
Ceftriaxone—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000975	0.00427	CcSEcCtD
Ceftriaxone—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000973	0.00426	CcSEcCtD
Ceftriaxone—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00097	0.00425	CcSEcCtD
Ceftriaxone—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000968	0.00424	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000957	0.00419	CcSEcCtD
Ceftriaxone—Pancreatitis—Prednisone—ankylosing spondylitis	0.000939	0.00412	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisone—ankylosing spondylitis	0.000933	0.00409	CcSEcCtD
Ceftriaxone—Neutropenia—Prednisone—ankylosing spondylitis	0.000895	0.00393	CcSEcCtD
Ceftriaxone—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000885	0.00388	CcSEcCtD
Ceftriaxone—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000885	0.00388	CcSEcCtD
Ceftriaxone—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00088	0.00386	CcSEcCtD
Ceftriaxone—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00088	0.00386	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—ankylosing spondylitis	0.000871	0.00382	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000852	0.00373	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000834	0.00366	CcSEcCtD
Ceftriaxone—Malaise—Prednisolone—ankylosing spondylitis	0.000828	0.00363	CcSEcCtD
Ceftriaxone—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000827	0.00362	CcSEcCtD
Ceftriaxone—Convulsion—Prednisolone—ankylosing spondylitis	0.000796	0.00349	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000792	0.00347	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000785	0.00344	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000783	0.00343	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000782	0.00343	CcSEcCtD
Ceftriaxone—Discomfort—Prednisolone—ankylosing spondylitis	0.000772	0.00339	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisone—ankylosing spondylitis	0.00077	0.00338	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisone—ankylosing spondylitis	0.000766	0.00336	CcSEcCtD
Ceftriaxone—Malaise—Triamcinolone—ankylosing spondylitis	0.000761	0.00334	CcSEcCtD
Ceftriaxone—Malaise—Methylprednisolone—ankylosing spondylitis	0.00076	0.00333	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000749	0.00329	CcSEcCtD
Ceftriaxone—Oedema—Prednisolone—ankylosing spondylitis	0.000749	0.00329	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—ankylosing spondylitis	0.000748	0.00328	CcSEcCtD
Ceftriaxone—Convulsion—Triamcinolone—ankylosing spondylitis	0.000732	0.00321	CcSEcCtD
Ceftriaxone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00073	0.0032	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000724	0.00318	CcSEcCtD
Ceftriaxone—Flushing—Prednisone—ankylosing spondylitis	0.000711	0.00312	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000711	0.00312	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000711	0.00312	CcSEcCtD
Ceftriaxone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00071	0.00311	CcSEcCtD
Ceftriaxone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000709	0.00311	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000707	0.0031	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—ankylosing spondylitis	0.000701	0.00307	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—ankylosing spondylitis	0.000696	0.00305	CcSEcCtD
Ceftriaxone—Malaise—Dexamethasone—ankylosing spondylitis	0.000691	0.00303	CcSEcCtD
Ceftriaxone—Malaise—Betamethasone—ankylosing spondylitis	0.000691	0.00303	CcSEcCtD
Ceftriaxone—Oedema—Triamcinolone—ankylosing spondylitis	0.000689	0.00302	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000689	0.00302	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000688	0.00301	CcSEcCtD
Ceftriaxone—Infection—Triamcinolone—ankylosing spondylitis	0.000685	0.003	CcSEcCtD
Ceftriaxone—Infection—Methylprednisolone—ankylosing spondylitis	0.000683	0.00299	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—ankylosing spondylitis	0.00068	0.00298	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—ankylosing spondylitis	0.000673	0.00295	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000673	0.00295	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000666	0.00292	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000666	0.00292	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000665	0.00291	CcSEcCtD
Ceftriaxone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000664	0.00291	CcSEcCtD
Ceftriaxone—Convulsion—Betamethasone—ankylosing spondylitis	0.000664	0.00291	CcSEcCtD
Ceftriaxone—Discomfort—Betamethasone—ankylosing spondylitis	0.000644	0.00283	CcSEcCtD
Ceftriaxone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000644	0.00283	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000644	0.00282	CcSEcCtD
Ceftriaxone—Pain—Prednisolone—ankylosing spondylitis	0.000641	0.00281	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000641	0.00281	CcSEcCtD
Ceftriaxone—Oedema—Dexamethasone—ankylosing spondylitis	0.000625	0.00274	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000625	0.00274	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000625	0.00274	CcSEcCtD
Ceftriaxone—Oedema—Betamethasone—ankylosing spondylitis	0.000625	0.00274	CcSEcCtD
Ceftriaxone—Infection—Dexamethasone—ankylosing spondylitis	0.000621	0.00272	CcSEcCtD
Ceftriaxone—Infection—Betamethasone—ankylosing spondylitis	0.000621	0.00272	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000619	0.00271	CcSEcCtD
Ceftriaxone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000619	0.00271	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000618	0.00271	CcSEcCtD
Ceftriaxone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000617	0.00271	CcSEcCtD
Ceftriaxone—Anaemia—Prednisone—ankylosing spondylitis	0.000617	0.0027	CcSEcCtD
Ceftriaxone—Agitation—Prednisone—ankylosing spondylitis	0.000613	0.00269	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000612	0.00268	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000612	0.00268	CcSEcCtD
Ceftriaxone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000607	0.00266	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000606	0.00266	CcSEcCtD
Ceftriaxone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000605	0.00265	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000604	0.00265	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000604	0.00265	CcSEcCtD
Ceftriaxone—Malaise—Prednisone—ankylosing spondylitis	0.000602	0.00264	CcSEcCtD
Ceftriaxone—Urticaria—Prednisolone—ankylosing spondylitis	0.000595	0.00261	CcSEcCtD
Ceftriaxone—Pain—Triamcinolone—ankylosing spondylitis	0.000589	0.00258	CcSEcCtD
Ceftriaxone—Convulsion—Prednisone—ankylosing spondylitis	0.000578	0.00253	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—ankylosing spondylitis	0.000575	0.00252	CcSEcCtD
Ceftriaxone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000568	0.00249	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000567	0.00248	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000562	0.00246	CcSEcCtD
Ceftriaxone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000561	0.00246	CcSEcCtD
Ceftriaxone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000561	0.00246	CcSEcCtD
Ceftriaxone—Discomfort—Prednisone—ankylosing spondylitis	0.000561	0.00246	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000552	0.00242	CcSEcCtD
Ceftriaxone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00055	0.00241	CcSEcCtD
Ceftriaxone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00055	0.00241	CcSEcCtD
Ceftriaxone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000547	0.0024	CcSEcCtD
Ceftriaxone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000546	0.00239	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000546	0.00239	CcSEcCtD
Ceftriaxone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000545	0.00239	CcSEcCtD
Ceftriaxone—Oedema—Prednisone—ankylosing spondylitis	0.000545	0.00239	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000545	0.00239	CcSEcCtD
Ceftriaxone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000544	0.00238	CcSEcCtD
Ceftriaxone—Infection—Prednisone—ankylosing spondylitis	0.000541	0.00237	CcSEcCtD
Ceftriaxone—Pain—Dexamethasone—ankylosing spondylitis	0.000535	0.00234	CcSEcCtD
Ceftriaxone—Pain—Betamethasone—ankylosing spondylitis	0.000535	0.00234	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000526	0.00231	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000517	0.00227	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—ankylosing spondylitis	0.000515	0.00226	CcSEcCtD
Ceftriaxone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000515	0.00226	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000515	0.00226	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000511	0.00224	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000511	0.00224	CcSEcCtD
Ceftriaxone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000508	0.00223	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000507	0.00222	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—ankylosing spondylitis	0.000503	0.0022	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000499	0.00219	CcSEcCtD
Ceftriaxone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000497	0.00218	CcSEcCtD
Ceftriaxone—Urticaria—Betamethasone—ankylosing spondylitis	0.000497	0.00218	CcSEcCtD
Ceftriaxone—Dizziness—Prednisolone—ankylosing spondylitis	0.000496	0.00217	CcSEcCtD
Ceftriaxone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000494	0.00217	CcSEcCtD
Ceftriaxone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000494	0.00217	CcSEcCtD
Ceftriaxone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000494	0.00217	CcSEcCtD
Ceftriaxone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000494	0.00217	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000489	0.00214	CcSEcCtD
Ceftriaxone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000488	0.00214	CcSEcCtD
Ceftriaxone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000486	0.00213	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—ankylosing spondylitis	0.000483	0.00212	CcSEcCtD
Ceftriaxone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000479	0.0021	CcSEcCtD
Ceftriaxone—Rash—Prednisolone—ankylosing spondylitis	0.000473	0.00207	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000472	0.00207	CcSEcCtD
Ceftriaxone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00047	0.00206	CcSEcCtD
Ceftriaxone—Headache—Prednisolone—ankylosing spondylitis	0.000469	0.00206	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—ankylosing spondylitis	0.000469	0.00206	CcSEcCtD
Ceftriaxone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000456	0.002	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000455	0.002	CcSEcCtD
Ceftriaxone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000455	0.00199	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—ankylosing spondylitis	0.000452	0.00198	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000449	0.00197	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000446	0.00195	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000445	0.00195	CcSEcCtD
Ceftriaxone—Nausea—Prednisolone—ankylosing spondylitis	0.000445	0.00195	CcSEcCtD
Ceftriaxone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000442	0.00194	CcSEcCtD
Ceftriaxone—Pruritus—Betamethasone—ankylosing spondylitis	0.000442	0.00194	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00044	0.00193	CcSEcCtD
Ceftriaxone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000438	0.00192	CcSEcCtD
Ceftriaxone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000437	0.00192	CcSEcCtD
Ceftriaxone—Rash—Triamcinolone—ankylosing spondylitis	0.000435	0.0019	CcSEcCtD
Ceftriaxone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000434	0.0019	CcSEcCtD
Ceftriaxone—Rash—Methylprednisolone—ankylosing spondylitis	0.000434	0.0019	CcSEcCtD
Ceftriaxone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000433	0.0019	CcSEcCtD
Ceftriaxone—Urticaria—Prednisone—ankylosing spondylitis	0.000433	0.0019	CcSEcCtD
Ceftriaxone—Headache—Triamcinolone—ankylosing spondylitis	0.000432	0.00189	CcSEcCtD
Ceftriaxone—Headache—Methylprednisolone—ankylosing spondylitis	0.000431	0.00189	CcSEcCtD
Ceftriaxone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00043	0.00189	CcSEcCtD
Ceftriaxone—Body temperature increased—Prednisone—ankylosing spondylitis	0.00043	0.00189	CcSEcCtD
Ceftriaxone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000428	0.00188	CcSEcCtD
Ceftriaxone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000428	0.00188	CcSEcCtD
Ceftriaxone—Dizziness—Betamethasone—ankylosing spondylitis	0.000413	0.00181	CcSEcCtD
Ceftriaxone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000413	0.00181	CcSEcCtD
Ceftriaxone—Nausea—Triamcinolone—ankylosing spondylitis	0.000409	0.00179	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000409	0.00179	CcSEcCtD
Ceftriaxone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000408	0.00179	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000401	0.00176	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000401	0.00176	CcSEcCtD
Ceftriaxone—Vomiting—Betamethasone—ankylosing spondylitis	0.000398	0.00174	CcSEcCtD
Ceftriaxone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000398	0.00174	CcSEcCtD
Ceftriaxone—Rash—Betamethasone—ankylosing spondylitis	0.000394	0.00173	CcSEcCtD
Ceftriaxone—Rash—Dexamethasone—ankylosing spondylitis	0.000394	0.00173	CcSEcCtD
Ceftriaxone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000394	0.00173	CcSEcCtD
Ceftriaxone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000394	0.00173	CcSEcCtD
Ceftriaxone—Headache—Dexamethasone—ankylosing spondylitis	0.000392	0.00172	CcSEcCtD
Ceftriaxone—Headache—Betamethasone—ankylosing spondylitis	0.000392	0.00172	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—ankylosing spondylitis	0.000389	0.00171	CcSEcCtD
Ceftriaxone—Pruritus—Prednisone—ankylosing spondylitis	0.000385	0.00169	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000375	0.00164	CcSEcCtD
Ceftriaxone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000373	0.00163	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000372	0.00163	CcSEcCtD
Ceftriaxone—Nausea—Betamethasone—ankylosing spondylitis	0.000371	0.00163	CcSEcCtD
Ceftriaxone—Nausea—Dexamethasone—ankylosing spondylitis	0.000371	0.00163	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—ankylosing spondylitis	0.000362	0.00158	CcSEcCtD
Ceftriaxone—Dizziness—Prednisone—ankylosing spondylitis	0.00036	0.00158	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00036	0.00158	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00036	0.00158	CcSEcCtD
Ceftriaxone—Vomiting—Prednisone—ankylosing spondylitis	0.000346	0.00152	CcSEcCtD
Ceftriaxone—Rash—Prednisone—ankylosing spondylitis	0.000343	0.00151	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisone—ankylosing spondylitis	0.000343	0.0015	CcSEcCtD
Ceftriaxone—Headache—Prednisone—ankylosing spondylitis	0.000341	0.0015	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000335	0.00147	CcSEcCtD
Ceftriaxone—Nausea—Prednisone—ankylosing spondylitis	0.000323	0.00142	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—ankylosing spondylitis	0.000322	0.00141	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000311	0.00137	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—ankylosing spondylitis	0.000301	0.00132	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—ankylosing spondylitis	0.000289	0.00127	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—ankylosing spondylitis	0.000287	0.00126	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000287	0.00126	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—ankylosing spondylitis	0.000285	0.00125	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—ankylosing spondylitis	0.00027	0.00119	CcSEcCtD
